Kashani-Sabet M - Search Results

1

Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma.

Dar AA, Bezrookove V, Nosrati M, Ice R, Patino JM, Vaquero EM, Parrett B, Leong SP, Kim KB, Debs RJ, Soroceanu L, Miller JR 3rd, Desprez PY, Cleaver JE, Salomonis N, McAllister S, Kashani-Sabet M. Dar AA, et al. Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2206824119. doi: 10.1073/pnas.2206824119. Epub 2022 Aug 15. Proc Natl Acad Sci U S A. 2022. PMID: 35969744 Free PMC article.

2

Nucleotide excision repair "a legacy of creativity".

Cleaver JE, Karplus K, Kashani-Sabet M, Limoli CL. Cleaver JE, et al. Mutat Res. 2001 Feb 25;485(1):23-36. doi: 10.1016/s0921-8777(00)00073-2. Mutat Res. 2001. PMID: 11341991 Review.

3

Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice.

Kashani-Sabet M, Liu Y, Fong S, Desprez PY, Liu S, Tu G, Nosrati M, Handumrongkul C, Liggitt D, Thor AD, Debs RJ. Kashani-Sabet M, et al. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3878-83. doi: 10.1073/pnas.002025599. Epub 2002 Mar 12. Proc Natl Acad Sci U S A. 2002. PMID: 11891271 Free PMC article.

4

Tumor vascularity in the prognostic assessment of primary cutaneous melanoma.

Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR 3rd. Kashani-Sabet M, et al. J Clin Oncol. 2002 Apr 1;20(7):1826-31. doi: 10.1200/JCO.2002.07.082. J Clin Oncol. 2002. PMID: 11919240

5

Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).

Zettersten E, Sagebiel RW, Miller JR 3rd, Tallapureddy S, Leong SP, Kashani-Sabet M. Zettersten E, et al. Cancer. 2002 Feb 15;94(4):1049-56. Cancer. 2002. PMID: 11920475 Free article.

6

Altered clinical course of malignant melanoma in HIV-positive patients.

Rodrigues LK, Klencke BJ, Vin-Christian K, Berger TG, Crawford RI, Miller JR 3rd, Ferreira CM, Nosrati M, Kashani-Sabet M. Rodrigues LK, et al. Arch Dermatol. 2002 Jun;138(6):765-70. doi: 10.1001/archderm.138.6.765. Arch Dermatol. 2002. PMID: 12056957

7

Delayed harvesting of sentinel lymph nodes after previous wide local excision of extremity melanoma.

Leong SP, Thelmo MC, Kim RP, Gokhale R, Rhee JY, Achtem TA, Morita E, Allen RE Jr, Kashani-Sabet M, Sagebiel RW. Leong SP, et al. Ann Surg Oncol. 2003 Mar;10(2):196-200. doi: 10.1245/aso.2003.08.002. Ann Surg Oncol. 2003. PMID: 12620917

8

Functional identification of distinct sets of antitumor activities mediated by the FKBP gene family.

Fong S, Mounkes L, Liu Y, Maibaum M, Alonzo E, Desprez PY, Thor AD, Kashani-Sabet M, Debs RJ. Fong S, et al. Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14253-8. doi: 10.1073/pnas.2332307100. Epub 2003 Nov 11. Proc Natl Acad Sci U S A. 2003. PMID: 14612567 Free PMC article.

9

NF-kappa B in the vascular progression of melanoma.

Kashani-Sabet M, Shaikh L, Miller JR 3rd, Nosrati M, Ferreira CM, Debs RJ, Sagebiel RW. Kashani-Sabet M, et al. J Clin Oncol. 2004 Feb 15;22(4):617-23. doi: 10.1200/JCO.2004.06.047. J Clin Oncol. 2004. PMID: 14966085

10

Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.

Nosrati M, Li S, Bagheri S, Ginzinger D, Blackburn EH, Debs RJ, Kashani-Sabet M. Nosrati M, et al. Clin Cancer Res. 2004 Aug 1;10(15):4983-90. doi: 10.1158/1078-0432.CCR-04-0134. Clin Cancer Res. 2004. PMID: 15297398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page